Prevalence and risk factors for long COVID after mild disease: A cohort study with a symptomatic control group.
Cazé AB, Cerqueira-Silva T, Bomfim AP, de Souza GL, Azevedo AC, Brasil MQ, Santos NR, Khouri R, Dan J, Bandeira AC, Cavalcanti LP, Barral-Netto M, Barral A, Barbosa CG, Boaventura VS.
Cazé AB, et al. Among authors: de souza gl.
J Glob Health. 2023 May 12;13:06015. doi: 10.7189/jogh.13.06015.
J Glob Health. 2023.
PMID: 37166260
Free PMC article.